Anticancer Res 2000,
PMID: 10953307
Anderson, K M; Alrefai, W A; Bonomi, P A; Anderson, C A; Dudeja, P; Harris, J E
Incomplete programmed cell death is one explanation for the escape of cancer cells from therapy. Inhibitors of the enzyme 5-lipoxygenase reduce proliferation and initiate programmed cell death in many different types of malignantly transformed cells. The 5-lipoxygenase inhibitor, MK 886. induces an atypical form of programmed cell death in H-358 bronchiolar lung cancer cells. A genomic response of H-358 cells after 24 hr of culture at a 40 uM concentration that inhibited proliferation was analyzed with a Clontech human cDNA array containing 588 cDNAs corresponding to identified genes. The data grouped into 3 major categories and initial conclusions regarding countervailing, cellular stress, programmed cell death, DNA damage and repair mRNA-responses as possible reasons for escape from the antiproliferative response are discussed. The use of cDNA arrays to estimate the extent to which malignantly transformed cells respond to therapy or why they do not and so infer prognosis and identify possible therapeutic modifications is indicated.
Diseases/Pathways annotated by Medline MESH: Adenocarcinoma, Bronchiolo-Alveolar, Lung Neoplasms
Document information provided by NCBI PubMed
Text Mining Data
programmed cell death ⊣ 5-lipoxygenase: "
Inhibitors of the enzyme
5-lipoxygenase reduce proliferation and
initiate programmed cell death in many different types of malignantly transformed cells
"
Manually curated Databases